Search

Displaying results 9051 - 9060 of 10000 in total
  1. Drug

    CT103A

    go.drugbank.com/drugs/DB18180
    Investigational

    CT103A is an investigational BCMA-targeted genetically modified autologous T-cell immunotherapy.

  2. Drug

    CT120

    go.drugbank.com/drugs/DB18181
    Investigational

    CT120 is an investigational autologous CD19/22 targeted CAR-T cell immunotherapy.

  3. Drug

    CAM-101

    go.drugbank.com/drugs/DB18414
    Investigational

    CAM-101 is an allogeneic human platelet lysate product depleted of fibrinogen.

  4. Drug

    Salanersen

    go.drugbank.com/drugs/DB18418
    Investigational

    BIIB115 is an investigational antisense oligonucleotide in development for spinal muscular atrophy.

  5. Drug

    Cendakimab

    go.drugbank.com/drugs/DB18427
    Investigational

    Cendakimab is a recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody.

    Synonyms: )) (10.7.15) (1-123) -HOMO SAPIENS IGHG1*03V, G1M3>G, .-1), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL RPC4046 .KAPPA.-1, DIMER
  6. Drug

    AVX-470

    go.drugbank.com/drugs/DB18455
    Investigational

    AVX-470 is an anti-tumor necrosis factor (TNF) polyclonal antibody (bovine).

  7. Drug

    VBI-1901

    go.drugbank.com/drugs/DB18476
    Investigational

    VBI-1901 is a bivalent cytomeglaovirus gB/pp65 enveloped virus-like particles

  8. Drug

    JAK4D

    go.drugbank.com/drugs/DB18527
    Experimental

    JAK4D is a first-in-class thyrotropin-releasing hormone (TRH)-based compound.

    Synonyms: 5-oxo-l-prolyl-l-asparaginyl-l-prolyl-d-tyrosyl-d-tryptophanamide, L-pyroglutamyl-l-asparaginyl-l-prolyl-d-tyrosyl-d-tryptophan amide
  9. Drug

    TTX-siPDL1

    go.drugbank.com/drugs/DB18550
    Experimental

    TTX-siPDL1 is an siRNA-based modulator of programmed death-ligand 1.

    Synonyms: Magnetic nanocarrier-conjugated small interfering RNA against programmed death ligand 1
  10. Drug

    PA3-17

    go.drugbank.com/drugs/DB18569
    Investigational

    PA3-17 is CD7-directed chimeric antigen receptor (CAR) T-cell therapy.

    Synonyms: Chimeric Antigen Receptor T Cells targeting CD7